Zivox (linezolid) solution for infusions 2 mg/ml. 300 ml. №1


Manufacturer: Norway



Treatment of infections caused by sensitive strains of anaerobic or aerobic gram-positive microorganisms, including infections accompanied by bacteremia, such as: nosocomial pneumonia; non-hospital pneumonia; complicated infections of the skin and its structures, including infections with diabetic foot without concomitant osteomyelitis, caused by Staphylococcus aureus (methicillin-sensitive and methicillin-resistant isolates), Streptococcus pyogenes or Streptococcus agalactiae; uncomplicated infections of the skin and its structures caused by Staphylococcus aureus (methicillin-sensitive isolates only) or Streptococcus pyogenes; infections caused by enterococci, including vancomycin resistant strains of Enterococcus faecium and faecalis. If the pathogens include gram-negative microorganisms, the purpose of combination therapy is clinically indicated.